Europe (WHO region) vs Niue: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Europe (WHO region)
89.0%
in 2025
Niue
99.0%
in 2025
Europe (WHO region) rank
3rd
Niue rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Europe (WHO region)
- Niue
How they compare
Niue currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Niue's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Niue ahead.
Europe (WHO region) ranks 3rd and Niue ranks 1st of 11 groups.
Niue has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Niue | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.6% | 93.9% | 23.3% | Niue |
| 2010s | 87.3% | 98.8% | 11.5% | Niue |
| 2020s | 89.5% | 99.0% | 9.5% | Niue |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Europe (WHO region) or Niue?
- Niue, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Europe (WHO region) and Niue?
- 10.0%, with Niue ahead.
- How many years of comparable data are there for Europe (WHO region) and Niue?
- 26 years are reported by both, from 2000 to 2025.
- How do Europe (WHO region) and Niue rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Europe (WHO region) ranks 3rd and Niue ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.